BTIG analyst Michael Gorman raised the firm’s price target on Agree Realty (ADC) to $78 from $74 and keeps a Buy rating on the shares. Agree ...

Fintel reports that on November 27, 2024, BTIG upgraded their outlook for Embecta (NasdaqGS:EMBC) from Neutral to Buy. Analyst Price Forecast Suggests 20.45% Downside As of November 21, 2024, the ...

Specialty Finance Analyst Caintic holds a meeting with CEO Howard and CFO McCamey in Boston on December 4 hosted by BTIG.Don't Miss our Black ...

Notable insider trades include Wang Junyuan Jerry, CEO, ANHEART THERAPEUTICS LTD. at Nuvation Bio Inc (NUVB), who sold 56361 shares on Nov 11 ’24, at $2.89 each, totaling $0.16 million.

On Tuesday, Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $14.38 which represents a slight increase of $1.12 or 8.45% from the prior close of $13.26. The stock opened at $13.

A selloff in giant technology companies dragged down stocks, while the latest economic data gave support to the Federal ...

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

It isn't all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech's XLK 1.5% fall ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 results. Read more here.

Alector (NASDAQ:ALEC – Free Report) had its target price lowered by BTIG Research from $16.00 to $5.00 in a research note ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...

"An effort to repeal the IRA's tax credits would be met with opposition from numerous fronts, including constituencies supporting solar, wind, nuclear, hydrogen, hydro, alternative fuels and energy ...